Skip to main navigation
Search for:
Search
Rubius Therapeutics
About Us
Our Story
Leadership Team
Board of Directors
Scientific Advisory Board
Giving Back
Vision & Values
Diversity Statement
Our Science
Overview
Red Cell Therapeutics[TM]
Therapeutic Modalities
MOA Video
Manufacturing
Publications
Our Pipeline
Pipeline Overview
Therapeutic Areas
Clinical Trials
RTX-240 – Solid Tumors
RTX-240 – AML
RTX-321 – HPV 16-Positive Cancers
RTX-224 – Solid Tumors
Patient Access
Investors & Media
Company Overview
Press Releases
Events & Presentations
Publications
Stock Information
Governance
Financials & Filings
Quarterly Results
Contact
Menu
Search
Event
Details
Rubius Therapeutics Strategic Update
Sep 13, 2022 at 7:30 AM EDT
Listen to webcast
Facebook
Twitter
LinkedIn